Cynata Therapeutics Limited (ASX:CYP)
Australia · Delayed Price · Currency is AUD 0.0130
0.00 (0.00%)
Jul 15, 2026, 3:18 PM AEST
Cynata Therapeutics Market Cap
Cynata Therapeutics has a market cap or net worth of 3.16 million as of July 14, 2026. Its market cap has decreased by -91.25% in one year.
Market Cap
3.16M
Enterprise Value
576.61K
Revenue
1.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since December 20, 2007, Cynata Therapeutics's market cap has decreased from 15.60M to 3.16M, a decrease of -79.71%. That is a compound annual growth rate of -8.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 3.41M | -95.84% |
| Dec 31, 2025 | 81.92M | 51.54% |
| Dec 31, 2024 | 54.06M | 140.75% |
| Dec 29, 2023 | 22.45M | -47.76% |
| Dec 30, 2022 | 42.98M | -44.95% |
| Dec 31, 2021 | 78.09M | -17.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cambium Bio | 11.07M |
| Vectus Biosystems | 9.84M |
| Invex Therapeutics | 7.89M |
| Tissue Repair | 6.65M |
| Bio-Gene Technology | 6.56M |
| Zelira Therapeutics | 5.95M |
| Acrux | 5.90M |
| Biotron | 5.40M |